AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Banca Ifis

Earnings Release Nov 8, 2018

4153_er_2018-11-08_f4406ab3-35f1-410e-839c-0fb32066b0b5.pdf

Earnings Release

Open in Viewer

Opens in native device viewer

FINANCIAL HIGHLIGHTS

Positive financial
performance

Net banking income at €403.6m (+7.5% vs. 9M2017) stemming from positive
contribution of both Enterprise segment as well as NPL segment

Operating cost well under control; loan loss provision increased due to two historical
large position

9M2018 Net profit €89m / 3Q18 €23m
Solid capital position
Shareholders' equity at €1.397m (slightly up vs. FY2017) with CET1 14.63% (15.64%
at 31 December 2017) and TCR 19.60% (21.07% at 31 December 2017) at Banca IFIS
Banking Group scope*

Best in class in Italian market: 29% government bond portfolio on net equity (€423m
of nominal value/€406m at fair value as of 9M2018)

Government bond portfolio negatively affected CET1 -20 bps as of 9M2018 (-8 bps in
3Q18)
Strong liquidity
position

€1.3BN deposit in Bank of Italy

LCR over 2000% vs minimum regulatory requirement of 100%

Continued effort on diversification as well as lengthening maturity funding profile

Fitch rating confirmed in Sep'18 as BB+ Outlook stable

* The reported total own funds ratio refers only to the scope of the Banca IFIS Group, thus excluding the effects of the prudential consolidation in the parent La Scogliera S.p.A. The CET1 at 30 September 2018 including La Scogliera S.p.A. amounted to 10.67%. compared to 11.66% at 31 December 2017, while the Total Own Funds Ratio totalled 14.74%, compared to 16.15% at 31 December 2017.

CONSIDERATIONS ON THE 3Q/9M RESULTS

For comparison purposes the financials included in this Presentation, as a consequence of IFRS 9 introduction and redefinition of operating segments of the Bank are compared with those at 1 January 2018, whereas in the case of the income statement the comparative information has been re-aggregated to ensure accounting consistency with the corresponding amounts at 30 September 2018.

  • Quarterly key trends overall confirming positive developments of Enterprise segment and its commercial network for the "industrial" business component
  • Corporate banking area down vs. 9M17 mainly due to lower PPA reversal (€14m vs €24m in 3Q2017 and €-28m year on year)
  • Higher loan loss provisions in 9M2018 in Trade Receivables Area (€54.5m vs €16.0m in 9M2017) mainly as a consequence of two historical large positions
  • NPL Segment took advantage of good opportunities restarting with purchase in 3Q2018 (€103m of net book value unsecured NPL vs €239m FY2017)
  • Valuation risk model metrics extended to larger portion of the NPL portfolio contributes to positive income (€27m net of related costs) which will continue in the next quarters
  • Completed acquisition of 70% of Credifarma. Key step to become leader in specialty finance for Italian pharmacies

MARGINS (NBI* and NPFA**)

(€m)

NBI: €403.6m

(€375.3m 9M 2017) +7.5%

NPFA : € 334.6m

(€386.3m 9M 2017) -13.4%

Enterprises segment includes:

  • Trade receivables & M/L term lending
  • Corporate banking

▪ Leasing

▪ Tax receivables

Data
9M
Enterprises NPL Area G&S Total
NBI
2018(€m)
241.6 168.2 -6.2 403.6
NBI 2017 (€m) 260.6 108.4 6.3 375.3
% Change -7.3% +55.3% n.s. +7.5%
NPFA
2018
(€m)
173.1 168.2 -6.7 334.6
NPFA 2017 (€m) 270.7 108.4 7.2 386.3
% Change -36.1% +55.3% n.s. -13.4%

4

TRADE RECEIVABLES (FACTORING + M/L TERM LENDING)

  • Strong performance of commercial network: turnover at +20,0% vs 9M2017 (€9.5bn) and # of factoring clients +9,9% vs 9M2017
  • Loans to customers at €3.4bn (+0,1% vs 1Jan2018)

▪ NBI +12,6% in 9M2018 vs 9M2017 as increase in turnover more than counterbalance slight pressure on margins

▪ NPFA decrease in 9M2018 vs. 9M2017 due to €54.5m provisions (€16.0m in 9M2017) mainly related to two large relevant historical positions

CORPORATE BANKING

  • Strong contribution from commercial network with new loans at €225m in 9M2018 (+8.4% vs. 9M2017) that more than offset the decrease in the run off portfolio
  • Loans to customers at €802m (+18% vs 1Jan18) mainly driven by Structured Finance
  • New loans margin in line with comparable period of previous year
  • Decrease in NBI/NPFA from lower PPA reversal (€50m in 9M2018 vs €78m in 9M2017) and lower positive contribution from Asset valued at FV through P&L (+€8m in 9M2018 vs +€16m in 9M2017)
  • Decrease in NPFA mainly due to higher net impairment losses driven by 9M2017 significant releases of workout & recovery

  • Strong contribution from commercial network with new loans at €503m (+8,0% vs 9M2017)

  • Loans to customers increased by 5,9% (vs. 1Jan18)

▪ NBI for 9M2018 in line with 9M2017 as increase in volumes offset decrease in margin on new loans and maturity of older portfolio at higher yields

▪ NPFA for 9M2018 lower than 9M2017 due to slightly higher loan loss provisions

NPL AREA

  • NPL portfolio gross and net book value as of 9M2018 stood at €14.7bn and €945m respectively
  • Banca IFIS took advantage of market opportunity in 3Q18 acquiring new unsecured NPL portfolios for €1.8bn; average price again in area 5%
  • Strong performance with NPFA at €168m for 9M2018 (+55% vs. 9M2017)
  • Valuation risk model metrics extended to larger portion of the NPL portfolio previously at cost contribute to positive income (€27m net of related costs) which will continue in the next quarters
  • The NPFA is also positively impacted by the effect of some disposal but less than 9M2017 (€7.5m vs €17.7m 9M2017)

NPL AREA

  • Total Positions: 1.6m

  • Total Debtors: 1.1m

  • Average Ticket: €9k
  • Strong collection capabilities for Banca IFIS

Quarter Cash Collected (€m)

2016 2017 2018
1Q 17 25 40
2Q 18 29 41
3Q 21 30 45
Total 56 84 126
+52% +49%

Year Cash Collected (€m)

NPL AREA

OPERATING COSTS

  • Personnel expenses at €83.3m for 9M2018 (+12.9% vs 9M2017) in line with the growth of the employees (1,622 vs 1,433, +13.2%). Increase due also to the first consolidation of Capitalfin and Credifarma
  • Other expenses at €125.6m for 9M2018 vs €106.9m (+17.4% vs 9M2017) including €20.1m of recovery costs of NPL portfolio previous at cost at which was applied the risk model valuation. Also included €3.9m of gain on bargain purchase from Credifarma business combination
  • Cost/income ratio at 51.8% at 9M2018 vs 50.1% at 9M2017

11 *Other expenses include: Other administrative expenses, Net allocations to provisions for risks and charges, Net impairment losses/reversal on property, plant and equipment, on intangible assets and Other operating income/expenses.

NET PROFIT

BALANCE SHEET – ASSET STRUCTURE

(€m) % change 30-Sep-2018 vs 01-Jan-2018

Main impact from adoption of IFRS9

Excess of liquidity as a buffer for bank's ongoing activities

Expected reduction in DTA for future profitability

ASSET QUALITY & NPE TREND IN ENTERPRISES SEGMENT

9M 2018 €m

30-Sep-2018 01-Jan-2018
Gross NPE 641 564
Gross NPE/Loans 10.7% 9.9%
Net NPE 362 338
% Net NPE/Loans 6.4% 6.2%
Cost of credit 160 bps 31 bps
€m 30-Sep-2018 01-Jan-2018
Net Bad Loans 74.5 62.9
Coverage 70.7% 71.0%
Net
UTP
165.0 163.1
Coverage 33.9% 26.5%
Net Past
Due
122.4 112.0
Coverage 10.7% 10.6%
  • According to IFRS 9 new POCI category and new writeoff policy, the amounts of gross NPE are significantly changed
  • NPE Ratio and Coverage almost in line with Jan'18
  • 9M2018 Cost of credit significantly affected by provisions related to two historical large position (65bps excluding these ones).

FUNDING STRUCTURE

9M 2018 €m

Strong liquidity position

  • 2018 pre-funding activity through Senior Bond issuance in April 2018
  • Funding rebalancing between retail and wholesale funding sources remain the Bank's main strategy
  • Restructuring of ABS transaction with widening of securitized portfolio perimeter and decrease of funding cost
  • Increase of total funding duration and related funding cost even if marginal at 9M2018
  • TLTRO transaction will expire in March 2021
  • LCR higher than 2000%

REGULATORY CAPITAL RATIO

9M 2018

Regulatory capital ratio
Banca
IFIS Banking Group scope*
2018 2017
30/09 31/12
Common
Equity Tier 1 Ratio (CET1)
14.63% 15.64%
Total
Own Fund Capital Ratio
19.60% 21.07%
Regulatory capital ratio 2018 2017
30/09 31/12
Common
Equity Tier 1 Ratio (CET1)
10.67% 11.66%
Total
Own Fund Capital Ratio
14.74% 16.15%

* The reported total own funds ratio refers only to the scope of the Banca IFIS Group, thus excluding the effects of the prudential consolidation in the parent La Scogliera S.p.A. Consolidated own funds, riskweighted assets and solvency ratios at 30 September 2018 were calculated based on the regulatory principles set out in Directive 2013/36/EU (CRD IV) and Regulation (EU) 575/2013 (CRR) dated 26 June 2013, which were transposed in the Bank of Italy's Circulars no. 285 and 286 of 17 December 2013. Article 19 of the CRR requires to include the unconsolidated holding of the banking Group in prudential consolidation.

This Presentation may contain written and oral "forward-looking statements". which includes all statements that do not relate solely to historical or current facts and which are therefore inherently uncertain. All forward-looking statements rely on a number of assumptions. expectations. projections and provisional data concerning future events and are subject to a number of uncertainties and other factors. many of which are outside the control of Banca IFIS. (the "Company"). There are a variety of factors that may cause actual results and performance to be materially different from the explicit or implicit contents of any forward-looking statements and thus. such forward-looking statements are not a reliable indicator of future performance. The Company undertakes no obligation to publicly update or revise any forward-looking statements. whether as a result of new information. future events or otherwise. except as may be required by applicable law. The information and opinions contained in this Presentation are provided as at the date hereof and are subject to change without notice. Neither this Presentation nor any part of it nor the fact of its distribution may form the basis of. or be relied on or in connection with. any contract or investment decision.

The information. statements and opinions contained in this Presentation are for information purposes only and do not constitute a public offer under any applicable legislation or an offer to sell or solicitation of an offer to purchase or subscribe for securities or financial instruments or any advice or recommendation with respect to such securities or other financial instruments. None of the securities referred to herein have been. or will be. registered under the U.S. Securities Act of 1933. as amended. or the securities laws of any state or other jurisdiction of the United States or in Australia. Canada or Japan or any other jurisdiction where such an offer or solicitation would be unlawful (the "Other Countries"). and there will be no public offer of any such securities in the United States. This Presentation does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States or the Other Countries.

Mariacristina Taormina, Manager charged with preparing the financial reports of Banca IFIS S.p.A., pursuant to the provisions of Art. 154 bis, paragraph 2 of Italian Legislative Decree no.58 dated 24 February 1998, declares that the financial information included into this document, the same exposed in the Consolidated Interim Report as at 30 September 2018, correspond to the related books and accounting records.

Neither the Company nor any member of Banca IFIS nor any of its or their respective representatives. directors or employees accept any liability whatsoever in connection with this Presentation or any of its contents or in relation to any loss arising from its use or from any reliance placed upon it.

Talk to a Data Expert

Have a question? We'll get back to you promptly.